These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 10987994)
1. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. Fundarò A; Cavalli R; Bargoni A; Vighetto D; Zara GP; Gasco MR Pharmacol Res; 2000 Oct; 42(4):337-43. PubMed ID: 10987994 [TBL] [Abstract][Full Text] [Related]
2. Correction: Santonocito et al. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer's Disease: Formulation Development and Optimization. Santonocito D; Raciti G; Campisi A; Sposito G; Panico A; Siciliano EA; Sarpietro MG; Damiani E; Puglia C Nanomaterials (Basel); 2023 Dec; 13(24):. PubMed ID: 38133068 [TBL] [Abstract][Full Text] [Related]
3. Stealth Migrations: Trillions of tiny animals may be coordinating their daily movements in ways that affect every organism on the planet. Harmon Courage K Sci Am; 2022 Aug; 327(2):48. PubMed ID: 39016801 [No Abstract] [Full Text] [Related]
4. Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues. Zara GP; Cavalli R; Bargoni A; Fundarò A; Vighetto D; Gasco MR J Drug Target; 2002 Jun; 10(4):327-35. PubMed ID: 12164381 [TBL] [Abstract][Full Text] [Related]
5. Solid lipid nanoparticles for parenteral drug delivery. Wissing SA; Kayser O; Müller RH Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin. Jiang SP; He SN; Li YL; Feng DL; Lu XY; Du YZ; Yu HY; Hu FQ; Yuan H Int J Nanomedicine; 2013; 8():3141-50. PubMed ID: 23990722 [TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy. Kang KW; Chun MK; Kim O; Subedi RK; Ahn SG; Yoon JH; Choi HK Nanomedicine; 2010 Apr; 6(2):210-3. PubMed ID: 20060074 [TBL] [Abstract][Full Text] [Related]
8. Lipid nanoemulsions loaded with doxorubicin-oleic acid ionic complex: characterization, in vitro and in vivo studies. Zhang X; Sun X; Li J; Zhang X; Gong T; Zhang Z Pharmazie; 2011 Jul; 66(7):496-505. PubMed ID: 21812324 [TBL] [Abstract][Full Text] [Related]
9. Coencapsulated doxorubicin and bromotetrandrine lipid nanoemulsions in reversing multidrug resistance in breast cancer in vitro and in vivo. Cao X; Luo J; Gong T; Zhang ZR; Sun X; Fu Y Mol Pharm; 2015 Jan; 12(1):274-86. PubMed ID: 25469833 [TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies. Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Biasibetti E; Capucchio MT; Valazza A; Panciani PP; Lanotte M; Schiffer D; Annovazzi L; Caldera V; Mellai M; Riganti C J Pharm Sci; 2014 Jul; 103(7):2157-2165. PubMed ID: 24824141 [TBL] [Abstract][Full Text] [Related]
11. Doxorubicin loading, release, and stability of polyamidoamine dendrimer-coated magnetic nanoparticles. Rouhollah K; Pelin M; Serap Y; Gozde U; Ufuk G J Pharm Sci; 2013 Jun; 102(6):1825-1835. PubMed ID: 23558592 [TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-loaded nanoparticles: new advances in breast cancer therapy. Prados J; Melguizo C; Ortiz R; Vélez C; Alvarez PJ; Arias JL; Ruíz MA; Gallardo V; Aranega A Anticancer Agents Med Chem; 2012 Nov; 12(9):1058-70. PubMed ID: 22339066 [TBL] [Abstract][Full Text] [Related]
13. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Gabizon A; Catane R; Uziely B; Kaufman B; Safra T; Cohen R; Martin F; Huang A; Barenholz Y Cancer Res; 1994 Feb; 54(4):987-92. PubMed ID: 8313389 [TBL] [Abstract][Full Text] [Related]